2009-11-10 03:19:02 -
ART Advanced Research Technologies, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - a new market research report on companiesandmarkets.com
www.companiesandmarkets.com/Summary-Company-Profile/art-advanced ..
ART Advanced Research Technologies, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Summary
ART Advanced Research Technologies Inc. (ART) is engaged in the research, design, development and commercialization of optical molecular imaging products. The company operates principally in two sectors: the medical sector and the pharmaceutical sector. The medical sector comprises of the research, design, development and marketing of SoftScan which is a time-domain optical breast imaging device. The pharmaceutical sector comprises of the research, design, development and commercialization of Optix and Fenestra products.
The ART Advanced Research Technologies, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile is an essential source for company data and information. The profile examines the companys key business structure and
operations, history and products, and provides summary analysis of its key revenue lines and strategy as well as highlighting the companys major recent financial deals.
Scope
- Provides key company information for business intelligence needs
- Gives information on the companys major recent financial deals including Mergers and Acquisitions, asset transactions, PE/VC deals, equity offerings, debt offerings and partnerships.
- Data is supplemented with details on the companys history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.
Reasons to buy
- A quick ""one-stop-shop"" to understand the company.
- Support sales activities by understanding your customers businesses.
- Qualify prospective partners and suppliers.
- Understand and respond to your competitors business structure, strategy and prospects through.
- Understanding the key deals which have shaped the company.
